Comparison of Low GI and High GI Potatoes in Relation to Satiety (POSAT)

NCT ID: NCT03512509

Last Updated: 2018-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-05

Study Completion Date

2018-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a single-blind, randomised crossover study, investigating how a high glycaemic potato affects satiety in humans compared to a low glycaemic potato. This is done to shed further light on the discussion about whether potatoes with a high glycaemic index increases the risk of overweight and obesity and thus indirectly type 2 diabetes and cardiovascular disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The POSAT study follows a single-blinded randomized crossover design. Each subject will have two separate intervention days with at least a six-day washout period in between. On the two intervention days the subjects will be randomized into receiving a breakfast containing isocaloric amounts of either low or high GI potatoes. VAS will be measured 5 minutes before the meal, immediately after the meal is consumed and in intervals of 30 minutes thereafter until 2,5 hours after the initial meal. After this the subjects will be served a standardized homogenous ad libitum meal. The amount of food consumed will be registered. The subjects will be asked to fast for 8-10 hours prior to the trial days and abstain from vigorous physical activity and alcohol consumption for 2 days prior to each trial day. The trial will be conducted over a total of 8 days with 5-6 study subjects pr. trial day. The trial days will be spread out over a total of 2 weeks to allow for a 1-week washout period between trial days for each subject.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Single-blind randomized crossover
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Subjets will not be aware of which test meal they will recieve first, and are not able to distinguish between the two potatoes.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Low glycaemic potato

Group Type EXPERIMENTAL

Low glycaemic potato

Intervention Type OTHER

The Carisma potato variety is used as the low glycaemic index potato.

B

High glycaemic potato

Group Type EXPERIMENTAL

High glycaemic potato

Intervention Type OTHER

The Arizona potato variety is used as the high glycaemic index potato.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low glycaemic potato

The Carisma potato variety is used as the low glycaemic index potato.

Intervention Type OTHER

High glycaemic potato

The Arizona potato variety is used as the high glycaemic index potato.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy men
* Body mass index (BMI) 18-27 kg/m2
* Age 18-40 years
* Signed informed consent
* Able to eat 500 grams of potato for breakfast

Exclusion Criteria

* Chronic diseases as diabetes, cardiovascular diseases or other chronic metabolic diseases, which could affect the results.
* Use of daily prescription medicine (mild analgesics and antihistamines are allowed).
* Use of medicine or dietary supplements that can affect ones appetite one month before the start of the study.
* Smoking or have been smoking or using any nicotine products (gum or e-cigarette) within the last 3 months. Irregular smoking is allowed.
* Elite athletes defined as doing \>10 hours of strenuous physical activity per week.
* Participation in other clinical studies \<1 month before or during the study.
* Inability, physically or psychologically, to comply with the procedures required by the study protocol. Judged by the investigators.
* Any food allergies.
* Weight change of ±3 kg from screening to the trial has been conducted.
* Inability to complete the trial within 3 months after screening.
* Unable to fast 8-10 hours before the trial days.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Anne Birgitte Raben

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne Birgitte Raben

Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Raben, Professor

Role: PRINCIPAL_INVESTIGATOR

Department of Nutrition, Sports and Exercise, University of Copenhagen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Copenhagen

Frederiksberg, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B344

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.